Early management of atrial fibrillation to prevent cardiovascular complications.
about
Emerging risk factors and the dose-response relationship between physical activity and lone atrial fibrillation: a prospective case-control studyEHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Predisposing factors for atrial fibrillation in the elderly.Patient-derived models link re-entrant driver localization in atrial fibrillation to fibrosis spatial pattern.Catheter ablation in patients with persistent atrial fibrillationAntiarrhythmic therapy of atrial fibrillation: are we treating too late?Commonly consumed beverages in daily life: do they cause atrial fibrillation?Republished: A straightforward guide to the basic science behind arrhythmogenesis.Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications.Molecular mechanisms of atrial fibrosis: implications for the clinic.The changing circumstance of atrial fibrillation - progress towards precision medicine.Diagnosis, pathophysiology, and management of exercise-induced arrhythmias.Early Cardioversion in Atrial Fibrillation: Earlier Is Better, but Not Always and (Maybe) Not Immediately.Changes in Left Atrial Transport Function in Patients Who Maintained Sinus Rhythm After Successful Radiofrequency Catheter Ablation for Atrial Fibrillation: A 1-Year Follow-Up Multislice Computed Tomography Study.Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores.EARLY: a pilot study on early diagnosis of atrial fibrillation in a primary healthcare centre.Functional Role and Mechanism of microRNA-28b in Atrial Myocyte in a Persistent Atrial Fibrillation Rat Model.Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetesHow does fibrosis promote atrial fibrillation persistence: in silico findings, clinical observations, and experimental data.Commentary: Atrial Fibrillation Dynamics and Ionic Block Effects in Six Heterogeneous Human 3D Virtual Atria with Distinct Repolarization Dynamics.The electrocardiogram as a predictor of successful pharmacological cardioversion and progression of atrial fibrillation.Sensitivity of reentrant driver localization to electrophysiological parameter variability in image-based computational models of persistent atrial fibrillation sustained by a fibrotic substrate.European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm SocieThe RACE-3 is on: double-locking sinus rhythm by upstream and downstream therapy.Arrhythmias: drugs and devices.Risk Factor Management in Atrial Fibrillation.EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm SocietEvolving perspectives for personalised management of patients with atrial fibrillation: Table 1The diagnosis and management of atrial fibrillation in the horseAtrial fibrillation
P2860
Q27301925-F7E5EE47-2AFE-49F4-BCA3-6501BF8406DDQ30375302-F71D42C0-CB99-413F-9E4D-70D5FA3BA14AQ33766891-38B2E359-EEAB-4E58-A44B-478A874F93C6Q36916733-4DA0C04F-CBDA-486B-9B76-CD59A929F70AQ37704983-C818CBD3-63D8-45A0-A119-6BBF42D0BA60Q38241801-12AC260E-CED8-4F16-8B69-616E8F2D1336Q38364435-6DD445AB-345E-47CC-8983-0A3D26B944C1Q38415718-C3225286-75CA-4A41-8B6D-8B648728BEB7Q38636457-38AF1408-2D6C-4897-AEDE-AFD0A0673B1AQ38749008-283846D9-1DCE-413E-ADBA-6F754A3B50BDQ38793865-50CAD3C9-F86A-43A1-AD7C-81FF7D817736Q39004326-171B7B27-50A4-4805-A2D2-F1CF28A16597Q39097180-E7F66401-C607-445E-BB51-7A63A47E7970Q39177081-BFF7E479-3D70-4361-B845-2C35374A58D1Q39958030-0687ED33-3D16-41DD-B694-805171B6A22BQ40288173-356B1BE5-8278-4D0A-B436-1CD8B605AB58Q40999374-B1995FC4-7170-4314-92CD-D73E3510875CQ42368137-A645687B-826D-4182-B2EB-8E489EFE2D68Q42776612-F0CCA6A1-6A19-495D-831E-F21C3CFD3C65Q47133944-0B2D1533-37C3-48CE-A995-8FCF3D38C0E0Q47583778-8D1C268F-F866-4CA4-95ED-2818E3D45533Q47615564-19A26E7E-5E39-4B35-AB18-43F4E0F5B054Q47796802-887C47D0-C85C-4DC9-865D-BE26FAA6B905Q50098979-E39CD039-287D-4837-91D6-1D5E77AD4CFAQ51838722-29B6BAD1-BC33-4F8E-B566-D42F25D8DF63Q55411533-0140ACA0-A735-426E-96CD-735A87F004C5Q55638585-294965A6-6702-422B-B041-7643B76A23DBQ57072097-D2521B10-691B-44B3-974E-B57BEDD508FBQ57626656-4B4E8B73-0CE5-4E9E-BED2-31C29CFC21EBQ57653488-348D12E9-76EC-4B07-AC4A-DEE48EA54ED6Q58645594-87F700E7-902C-43B1-88F3-74E3C77D9A04
P2860
Early management of atrial fibrillation to prevent cardiovascular complications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Early management of atrial fibrillation to prevent cardiovascular complications.
@en
type
label
Early management of atrial fibrillation to prevent cardiovascular complications.
@en
prefLabel
Early management of atrial fibrillation to prevent cardiovascular complications.
@en
P2093
P50
P356
P1476
Early management of atrial fibrillation to prevent cardiovascular complications.
@en
P2093
A John Camm
Dan Blendea
Francisco G Cosio
Irina Savelieva
Jennifer M Conroy
Jeremy Ruskin
Joseph De Bono
Paul L Hess
Sana M Al-Khatib
P304
P356
10.1093/EURHEARTJ/EHU028
P50
P577
2014-02-16T00:00:00Z